From a causal perspective, administration of flutamide (an androgen receptor blocker) to healthy normal-weight PCOS women attenuates accelerated lipid accumulation within these newly-formed adipocytes in vitro and increases fasting circulating glucose levels (but within the normal range) [79]. The gene discussed is AR; the disease is polycystic ovary syndrome.